Quarterly report pursuant to Section 13 or 15(d)

Nature of Business and Significant Accounting Policies (Details)

v3.21.2
Nature of Business and Significant Accounting Policies (Details)
 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 14, 2021
USD ($)
Oct. 31, 2018
USD ($)
Jun. 27, 2018
USD ($)
shares
Feb. 28, 2018
USD ($)
Dec. 04, 2017
USD ($)
Apr. 29, 2015
shares
Dec. 10, 2014
shares
Nov. 12, 2014
shares
Aug. 31, 2021
USD ($)
shares
Aug. 31, 2020
USD ($)
Aug. 31, 2019
USD ($)
shares
Feb. 28, 2021
USD ($)
May 31, 2021
USD ($)
May 31, 2020
USD ($)
Apr. 30, 2021
USD ($)
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions (in Shares) | shares             6,250,000                
Equity Method Investment, Ownership Percentage               55.60%              
Stockholders' Equity Note, Stock Split, Conversion Ratio             0.625                
Debt Instrument, Face Amount                             $ 6,229,672
Asset Impairment Charges                       $ 2,498,706 $ 2,498,706    
Financing Receivable, after Allowance for Credit Loss, Current $ 3,000,000 $ 5,000,000                          
Proceeds from Collection of Notes Receivable                 $ 1,174,082 $ 750,000          
Cash and Cash Equivalents, at Carrying Value                 1,961,091 2,887,102     1,665,263 $ 2,925,568  
Accounts Receivable, Credit Loss Expense (Reversal)                 0 $ 5,992 $ 5,992        
Goodwill     $ 25,742,899           557,896       557,896 557,896  
Advertising Expense                 446,666   132,032        
Research and Development Expense                 $ 600   $ 7,007        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                 110,062,032   88,399,315        
Principal [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Asset Impairment Charges                         2,497,884    
Accrued Interest [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Asset Impairment Charges                         822    
Reverse Merger with CLS Labs [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Stock Issued During Period, Shares, New Issues (in Shares) | shares           15,000,000                  
Oasis Acquisition [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Payments to Acquire Businesses, Gross       $ 6,200,000                      
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions       10.00%                      
Liabilities Assumed       $ 204,457                      
Oasis Acquisition [Member] | Deposit [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Payments to Acquire Businesses, Gross         $ 250,000                    
Oasis Acquisition [Member] | Additional Payments [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Payments to Acquire Businesses, Gross         $ 1,800,000                    
In Good Health [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Payments to Acquire Businesses, Gross   35,000,000                          
Business Combination, Consideration Transferred   47,500,000                          
Business Combination, Consideration Transferred, Liabilities Incurred   7,500,000                          
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned   5,000,000                          
Business Combination, Contingent Consideration, Liability   $ 2,500,000                          
Debt Instrument, Interest Rate, Stated Percentage   6.00%                          
Interest Rate, Default   15.00%                          
Financing Receivable, after Allowance for Credit Loss, Current                 $ 1,833,333       $ 0    
Proceeds from Collection of Notes Receivable                 1,174,082     $ 1,696,765   $ 1,425,000  
In Good Health [Member] | Principal [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Proceeds from Collection of Notes Receivable                 1,166,667            
In Good Health [Member] | Accrued Interest [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Proceeds from Collection of Notes Receivable                 $ 7,415            
In Good Health [Member] | Due And Payable On Or Before June 21, 2021 [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Proceeds from Collection of Notes Receivable 500,000                            
In Good Health [Member] | Due And Payable On Or Before July 12, 2021 [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Proceeds from Collection of Notes Receivable 500,000                            
In Good Health [Member] | Due And Payable In12 Monthly Installments [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Proceeds from Collection of Notes Receivable $ 2,000,000                            
Oasis LLCs [Member] | Oasis Acquisition [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Payments to Acquire Businesses, Gross     5,995,543                        
Debt Instrument, Face Amount     $ 4,000,000.0                        
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares) | shares     22,058,823                        
CLS Labs, Inc. [Member] | Shares of CLS Holdings USA, Inc. [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Subsidiary or Equity Method Investee, Cumulative Number of Shares Issued for All Transactions (in Shares) | shares               10,000,000              
Oasis LLCs [Member] | Oasis Acquisition [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners     90.00%                        
Warrant [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                 40,090,978   54,835,145        
Equity Unit Purchase Agreements [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                 3,041,290   7,676,974        
Convertible Debt Securities [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                 66,157,385   25,454,696        
Stock Payable [Member]                              
Nature of Business and Significant Accounting Policies (Details) [Line Items]                              
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares                     432,500